Reklamos anatomija, MB - company info and details

Company age: 6 y. 0 mo.

Update

Company overview

Company name Reklamos anatomija, MB
Company code 305646241
VAT code LT100019044715
Registered address Panevėžys, Pramonės g. 3C, LT-35289
Registration date 2020-10-22 Company age: 6 y.
Phone Phone
Email Email
Website None
Company manager For registered members only Log in
Revenue (2025) 62,555 € +92% History
Profit (2025) 6,933 € +71% History
Number of employees 0 History
Managed vehicles 1 List
Current SODRA debt 127 € Read more
Days of debt to SODRA per year 180 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Small partnership
NACE activity Activities of advertising agencies
Ownership form Private without foreign capital
Public sales amount, last 12 mos. 12,100 € List

Description

This description was generated by artificial intelligence.
Reklamos anatomija, MB (company code 305646241) is a private small partnership established on 22 October 2020 and currently operational. The company is classified as a micro-sized private non-financial enterprise with CEO-only governance and private ownership based on Lithuanian natural and legal persons holding more than 50% of authorised capital, with no foreign investor capital. Its main activity is NACE code N.73.11.00, Activities of advertising agencies. The company is based in Panevežys, Panevežio m. sav., Panevežio apskr., at Pramones g. 3C, LT-35289. Financially, the available figures show revenue of EUR 46.9 thousand in 2023, followed by EUR 32.6 thousand in 2024. Over the same period, net profit increased from EUR 815 to EUR 4.1 thousand, and the profit margin improved from 1.7% to 12.4%. Equity rose from EUR 3.1 thousand to EUR 7.2 thousand, while total assets increased from EUR 12.6 thousand to EUR 16.1 thousand. The available staff data show an average of 1 employee in 2023.

Download a detailed company report

Make confident decisions with all the information about Reklamos anatomija, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report